Liwasag, Lorena .
HRN: 06-90-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
METRONIDAZOLE 500MG (TAB)
03/15/2026
03/22/2026
ORAL
500mg
TID
H. Pylori Positive
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines